BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17425663)

  • 1. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Ohira T; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Zakai NA; Rosamond WD; Folsom AR
    J Thromb Haemost; 2007 Jul; 5(7):1455-61. PubMed ID: 17425663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors.
    Folsom AR; Cushman M; Tsai MY; Aleksic N; Heckbert SR; Boland LL; Tsai AW; Yanez ND; Rosamond WD
    Blood; 2002 Apr; 99(8):2720-5. PubMed ID: 11929758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
    Zakai NA; Lutsey PL; Folsom AR; Heckbert SR; Cushman M
    Thromb Haemost; 2010 Aug; 104(2):207-12. PubMed ID: 20431849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study.
    Larsen TB; Johnsen SP; Gislum M; Møller CA; Larsen H; Sørensen HT
    J Thromb Haemost; 2005 Feb; 3(2):300-4. PubMed ID: 15670036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.
    Lutsey PL; Folsom AR; Heckbert SR; Cushman M
    J Thromb Haemost; 2009 Oct; 7(10):1639-48. PubMed ID: 19656279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
    Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
    Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
    Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
    CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
    Shrivastava S; Ridker PM; Glynn RJ; Goldhaber SZ; Moll S; Bounameaux H; Bauer KA; Kessler CM; Cushman M
    J Thromb Haemost; 2006 Jun; 4(6):1208-14. PubMed ID: 16706961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.
    Vormittag R; Bencur P; Ay C; Tengler T; Vukovich T; Quehenberger P; Mannhalter C; Pabinger I
    J Thromb Haemost; 2007 Mar; 5(3):497-502. PubMed ID: 17155964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses.
    Keenan CR; Murin S; White RH
    J Thromb Haemost; 2007 Jun; 5(6):1185-90. PubMed ID: 17403099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of fibrinolytic markers and venous thromboembolism.
    Folsom AR; Cushman M; Heckbert SR; Rosamond WD; Aleksic N
    J Clin Epidemiol; 2003 Jun; 56(6):598-603. PubMed ID: 12873656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors.
    Ribeiro DD; Lijfering WM; Rosendaal FR; Cannegieter SC
    J Thromb Haemost; 2016 Aug; 14(8):1572-8. PubMed ID: 27214710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism--a manifestation of the metabolic syndrome.
    Ay C; Tengler T; Vormittag R; Simanek R; Dorda W; Vukovich T; Pabinger I
    Haematologica; 2007 Mar; 92(3):374-80. PubMed ID: 17339187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.
    Heinemann LA; Assmann A; Spannagl M; Schramm W; Dick A; Kluft C; de Maat MP
    Contraception; 1998 Nov; 58(5):321-2. PubMed ID: 9883389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism.
    Vormittag R; Vukovich T; Schönauer V; Lehr S; Minar E; Bialonczyk C; Hirschl M; Pabinger I
    Thromb Haemost; 2005 Mar; 93(3):488-93. PubMed ID: 15735799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
    Kraaijenhagen RA; in't Anker PS; Koopman MM; Reitsma PH; Prins MH; van den Ende A; Büller HR
    Thromb Haemost; 2000 Jan; 83(1):5-9. PubMed ID: 10669145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
    Kovac M; Kovac Z; Tomasevic Z; Vucicevic S; Djordjevic V; Pruner I; Radojkovic D
    Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
    Tsai AW; Cushman M; Rosamond WD; Heckbert SR; Tracy RP; Aleksic N; Folsom AR
    Am J Med; 2002 Dec; 113(8):636-42. PubMed ID: 12505113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.